Have a personal or library account? Click to login
Impact of Neu-botulinumtoxinA on the Severity and Quality of Life of Cervical Dystonia Patients Cover

Impact of Neu-botulinumtoxinA on the Severity and Quality of Life of Cervical Dystonia Patients

Tremor and Other Hyperkinetic Movements
Volume 6 (2016): Issue 0
By: Priya Jagota,  Lalita Kaewwilai,  Nonglak Boonrod,  Surat Singmaneesakulchai,  Kamolwan Boonpang,  Jirada Sringean,  Onanong Jitkritsadakul and  Sitthi Petchrutchatachart  
Open Access
|Aug 2016

References

  1. 1
    JinnahHABerardelliAComellaCet alThe focal dystonias: current views and challenges for future researchMov Disord201328926943doi: 10.1002/mds.2556723893450
    Back to article
  2. 2
    AlbaneseABhatiaKBressmanSBet alPhenomenology and classification of dystonia: a consensus updateMov Disord201328863873doi: 10.1002/mds.2547523649720
    Back to article
  3. 3
    AlbaneseAAbbruzzeseGDresslerDet alPractical guidance for CD management involving treatment of botulinum toxin: a consensus statementJ Neurol201526222012213doi: 10.1007/s00415-015-7703-x25877834
    Back to article
  4. 4
    WerleRWTakedaSYZontaMBGuimaraesATTeiveHAThe physical, social and emotional aspects are the most affected in the quality of life of the patients with cervical dystoniaArq Neuropsiquiatr201472405410doi: 10.1590/0004-282X2014004424964104
    Back to article
  5. 5
    MordinMMasaquelCAbbottCCopley-MerrimanCFactors affecting the health-related quality of life of patients with cervical dystonia and impact of treatment with abobotulinumtoxinA (Dysport): results from a randomised, double-blind, placebo-controlled studyBMJ Open20144e005150doi: 10.1136/bmjopen-2014-005150
    Back to article
  6. 6
    HefterHBeneckeRErbguthFJostWReichelGWisselJAn open-label cohort study of the improvement of quality of life and pain in de novo cervical dystonia patients after injections with 500 U botulinum toxin A (Dysport)BMJ Open2013317doi: 10.1136/bmjopen-2012-001853
    Back to article
  7. 7
    SlawekJFriedmanAPotulskaAet alFactors affecting the health-related quality of life of patients with cervical dystonia and the impact of botulinum toxin type A injectionsFunct Neurol2007229510017637212
    Back to article
  8. 8
    Ben-ShlomoYCamfieldLWarnerTESDE Collaborative GroupWhat are the determinants of quality of life in people with cervical dystonia?J Neurol Neurosurg Psychiatry200272608614doi: 10.1136/jnnp.72.5.60811971047
    Back to article
  9. 9
    SkogseidIMMaltUFRoislienJKertyEDeterminants and status of quality of life after long-term botulinum toxin therapy for cervical dystoniaEur J Neurol20071411291137doi: 10.1111/j.1468-1331.2007.01922.x17708754
    Back to article
  10. 10
    QueirozMRChienHFBarbosaERQuality of life in individuals with cervical dystonia before botulinum toxin injection in a Brazilian tertiary care hospitalArq Neuropsiquiatr201169900904doi: 10.1590/S0004-282X201100070001022297876
    Back to article
  11. 11
    CamfieldLBen-ShlomoYWarnerTTEpidemiological Study of Dystonia in Europe Collaborative GroupImpact of cervical dystonia on quality of lifeMov Disord200217838841doi: 10.1002/mds.1012712210891
    Back to article
  12. 12
    YoonJSKimJCLeeSYDouble-blind, randomized, comparative study of Meditoxin versus Botox in the treatment of essential blepharospasmKorean J Ophthalmol200923137141doi: 10.3341/kjo.2009.23.3.13719794937
    Back to article
  13. 13
    WonCHLeeHMLeeWSet alEfficacy and safety of a novel botulinum toxin type A product for the treatment of moderate to severe glabellar lines: a randomized, double-blind, active-controlled multicenter studyDermatol Surg201339171178doi: 10.1111/dsu.1207223301821
    Back to article
  14. 14
    KimKShinHIKwonBSKimSJJungIYBangMSNeuronox versus BOTOX for spastic equinus gait in children with cerebral palsy: a randomized, double-blinded, controlled multicentre clinical trialDev Med Child Neurol201153239244doi: 10.1111/j.1469-8749.2010.03830.x21087238
    Back to article
  15. 15
    NamHSParkYGPaikNJet alEfficacy and safety of NABOTA in post-stroke upper limb spasticity: a phase 3 multicenter, double-blinded, randomized controlled trialJ Neurol Sci2015357192197doi: 10.1016/j.jns.2015.07.02826233808
    Back to article
  16. 16
    SeoHGPaikNJLeeSUet alNeuronox versus BOTOX in the treatment of post-stroke upper limb spasticity: a multicenter randomized controlled trialPLoS One201510e0128633doi: 10.1371/journal.pone.012863326030192
    Back to article
  17. 17
    MullerJWisselJKemmlerGet alCraniocervical dystonia questionnaire (CDQ-24): development and validation of a disease-specific quality of life instrumentJ Neurol Neurosurg Psychiatry200475749753doi: 10.1136/jnnp.2003.01344115090572
    Back to article
  18. 18
    LeurmarnkulWMeetamPProperties testing of the retranslated SF-36 (Thai Version)Thai J Pharm Sci2005296988
    Back to article
  19. 19
    BrazierJEHarperRJonesNMet alValidating the SF-36 health survey questionnaire: new outcome measure for primary careBMJ1992305160164doi: 10.1136/bmj.305.6846.1601285753
    Back to article
  20. 20
    ChungMESongDHParkJHComparative study of biological activity of four botulinum toxin type A preparations in miceDermatol Surg201339155164doi: 10.1111/dsu.1207123301819
    Back to article
  21. 21
    SethiKDRodriguezROlayinkaBSatisfaction with botulinum toxin treatment: a cross-sectional survey of patients with cervical dystoniaJ Med Econ201215419423doi: 10.3111/13696998.2011.65372622208596
    Back to article
  22. 22
    HilkerRSchischniaschviliMGhaemiMJacobsARudolfJHealth related quality of life is improved by botulinum neurotoxin type A in long term treated patients with focal dystoniaJ Neurol Neurosurg Psychiatry200171193199doi: 10.1136/jnnp.71.2.19311459891
    Back to article
DOI: https://doi.org/10.5334/tohm.293 | Journal eISSN: 2160-8288
Journal RSS Feed
Language: English
Submitted on: May 25, 2016
Accepted on: Jul 5, 2016
Published on: Aug 4, 2016
Published by: Columbia University Libraries/Information Services
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
Cervical dystonia,
neu-botulinumtoxinA,
botulinum toxin,
quality of life

© 2016 Priya Jagota, Lalita Kaewwilai, Nonglak Boonrod, Surat Singmaneesakulchai, Kamolwan Boonpang, Jirada Sringean, Onanong Jitkritsadakul, Sitthi Petchrutchatachart, published by Columbia University Libraries/Information Services
This work is licensed under the Creative Commons License.

Previous articleVolume 6 (2016): Issue 0Next article